share_log

Stifel Initiates Coverage On Kura Oncology With Buy Rating, Announces Price Target of $25

Stifel Initiates Coverage On Kura Oncology With Buy Rating, Announces Price Target of $25

Stifel以买入评级开始对Kura Oncology进行报道,宣布目标价为25美元
Benzinga Real-time News ·  2023/01/31 04:37

Stifel analyst Bradley Canino initiates coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and announces Price Target of $25.

Stifel分析师布拉德利·卡尼诺对库拉肿瘤学(纳斯达克:库拉)的报道给予买入评级,并宣布目标价为25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发